Stock listing
BX Swiss:6C1 CytomX Therapeutics, Inc. Aktie
Swiss listing (BX Swiss) of CytomX Therapeutics, Inc. · home listing NASDAQ:CTMX
Follow CytomX Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CTMX
$2.51 USD +0.17 (+7.3%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CTMX
- Day range
- $2.35 – $2.55 USDOct 20, 2026
- Volume
- 4.07M sharesOct 20, 2026
- Market cap
- $546.9M USDAt the close on Oct 20, 2026 · price × 217.9M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CTMX · Home | $2.51 USD | +0.17 (+7.3%) | 4,074,083 | $2.36 | $2.55 | $2.345 | $2.34 | Close on Oct 20, 2026 |
| Frankfurt:6C1 | €2.051 EUR | +0.066 (+3.3%) | — | €2.051 | €2.051 | €2.051 | €1.986 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:CTMX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.51 | +0.17 | +7.3% | $2.36 | $2.55 | $2.345 | 4,074,083 | |
| $2.34 | +0.06 | +2.6% | $2.27 | $2.35 | $2.24 | 2,048,674 | |
| $2.28 | -0.13 | -5.4% | $2.40 | $2.435 | $2.26 | 3,178,659 | |
| $2.41 | +0.18 | +8.1% | $2.26 | $2.435 | $2.25 | 2,985,207 | |
| $2.23 | -0.095 | -4.1% | $2.30 | $2.345 | $2.20 | 3,350,872 | |
| $2.325 | -0.095 | -3.9% | $2.45 | $2.45 | $2.32 | 5,222,364 | |
| $2.42 | -0.15 | -5.8% | $2.56 | $2.575 | $2.41 | 2,459,771 | |
| $2.57 | +0.10 | +4.0% | $2.46 | $2.58 | $2.44 | 3,040,775 | |
| $2.47 | -0.08 | -3.1% | $2.51 | $2.545 | $2.43 | 4,502,552 | |
| $2.55 | -0.01 | -0.4% | $2.53 | $2.65 | $2.52 | 2,341,381 | |
| $2.56 | -0.02 | -0.8% | $2.61 | $2.63 | $2.505 | 1,955,800 | |
| $2.58 | +0.02 | +0.8% | $2.55 | $2.67 | $2.48 | 1,767,300 | |
| $2.56 | -0.07 | -2.7% | $2.68 | $2.68 | $2.55 | 2,624,100 | |
| $2.63 | -0.09 | -3.3% | $2.71 | $2.775 | $2.62 | 2,697,800 | |
| $2.72 | -0.03 | -1.1% | $2.78 | $2.80 | $2.70 | 3,220,700 | |
| $2.75 | +0.06 | +2.2% | $2.70 | $2.825 | $2.65 | 4,457,000 | |
| $2.69 | -0.01 | -0.4% | $2.68 | $2.76 | $2.60 | 2,693,900 | |
| $2.70 | -0.05 | -1.8% | $2.74 | $2.78 | $2.66 | 3,031,500 | |
| $2.75 | -0.03 | -1.1% | $2.75 | $2.78 | $2.68 | 3,079,000 | |
| $2.78 | -0.16 | -5.4% | $2.90 | $2.91 | $2.67 | 4,955,300 | |
| $2.94 | +0.18 | +6.5% | $2.86 | $2.995 | $2.76 | 7,923,000 | |
| $2.76 | 0.00 | 0.0% | $2.80 | $2.83 | $2.742 | 2,330,600 | |
| $2.76 | -0.06 | -2.1% | $2.83 | $2.86 | $2.72 | 9,595,800 | |
| $2.82 | +0.055 | +2.0% | $2.83 | $2.92 | $2.78 | 4,215,000 | |
| $2.765 | +0.075 | +2.8% | $2.72 | $2.865 | $2.671 | 6,866,200 | |
| $2.69 | -0.51 | -15.9% | $3.20 | $3.205 | $2.665 | 7,507,300 | |
| $3.20 | -0.09 | -2.7% | $3.335 | $3.36 | $3.145 | 6,138,700 | |
| $3.29 | -0.06 | -1.8% | $3.38 | $3.406 | $3.23 | 2,250,000 | |
| $3.35 | -0.19 | -5.4% | $3.50 | $3.52 | $3.335 | 2,058,000 | |
| $3.54 | -0.11 | -3.0% | $3.66 | $3.66 | $3.495 | 2,053,100 | |
| $3.65 | -0.06 | -1.6% | $3.612 | $3.66 | $3.58 | 1,984,600 | |
| $3.71 | +0.03 | +0.8% | $3.64 | $3.725 | $3.53 | 2,297,100 | |
| $3.68 | -0.04 | -1.1% | $3.73 | $3.82 | $3.61 | 2,556,800 | |
| $3.72 | +0.05 | +1.4% | $3.72 | $3.885 | $3.69 | 6,497,300 | |
| $3.67 | +0.31 | +9.2% | $3.32 | $3.73 | $3.32 | 8,820,600 | |
| $3.36 | +0.15 | +4.7% | $3.20 | $3.375 | $3.17 | 2,381,000 | |
| $3.21 | -0.21 | -6.1% | $3.40 | $3.42 | $3.21 | 2,173,300 | |
| $3.42 | +0.10 | +3.0% | $3.455 | $3.52 | $3.285 | 2,580,400 | |
| $3.32 | -0.05 | -1.5% | $3.35 | $3.38 | $3.285 | 2,216,300 | |
| $3.37 | +0.08 | +2.4% | $3.32 | $3.445 | $3.32 | 4,027,315 | |
| $3.29 | +0.01 | +0.3% | $3.30 | $3.38 | $3.175 | 3,191,674 | |
| $3.28 | -0.01 | -0.3% | $3.31 | $3.415 | $3.27 | 2,894,700 | |
| $3.29 | -0.28 | -7.8% | $3.53 | $3.56 | $3.27 | 2,605,400 | |
| $3.57 | +0.18 | +5.3% | $3.48 | $3.60 | $3.46 | 4,579,200 | |
| $3.39 | -0.06 | -1.7% | $3.41 | $3.435 | $3.30 | 2,456,500 | |
| $3.45 | +0.09 | +2.7% | $3.36 | $3.46 | $3.34 | 2,365,000 | |
| $3.36 | +0.01 | +0.3% | $3.34 | $3.385 | $3.28 | 1,433,000 | |
| $3.35 | -0.14 | -4.0% | $3.50 | $3.50 | $3.34 | 1,808,700 | |
| $3.49 | +0.04 | +1.2% | $3.48 | $3.535 | $3.415 | 2,518,900 | |
| $3.45 | +0.01 | +0.3% | $3.42 | $3.50 | $3.37 | 1,698,600 | |
| $3.44 | -0.02 | -0.6% | $3.45 | $3.495 | $3.385 | 1,795,800 | |
| $3.46 | +0.09 | +2.7% | $3.32 | $3.55 | $3.30 | 2,461,600 | |
| $3.37 | +0.02 | +0.6% | $3.31 | $3.40 | $3.29 | 1,937,300 | |
| $3.35 | +0.03 | +0.9% | $3.30 | $3.375 | $3.27 | 2,030,800 | |
| $3.32 | +0.15 | +4.7% | $3.23 | $3.33 | $3.215 | 2,436,900 | |
| $3.17 | +0.07 | +2.3% | $3.09 | $3.18 | $3.01 | 3,797,100 | |
| $3.10 | -0.18 | -5.5% | $3.26 | $3.281 | $3.10 | 3,502,200 | |
| $3.28 | +0.11 | +3.5% | $3.18 | $3.29 | $3.155 | 1,757,400 | |
| $3.17 | -0.05 | -1.6% | $3.21 | $3.35 | $3.15 | 1,364,300 | |
| $3.22 | -0.03 | -0.9% | $3.26 | $3.274 | $3.13 | 2,007,600 | |
| $3.25 | +0.01 | +0.3% | $3.25 | $3.43 | $3.25 | 2,500,700 | |
| $3.24 | -0.09 | -2.7% | $3.34 | $3.38 | $3.20 | 1,519,800 | |
| $3.33 | 0.00 | 0.0% | $3.31 | $3.405 | $3.275 | 1,381,300 | |
| $3.33 | -0.09 | -2.6% | $3.40 | $3.44 | $3.325 | 2,312,900 | |
| $3.42 | -0.10 | -2.8% | $3.50 | $3.545 | $3.39 | 5,960,225 | |
| $3.52 | -0.10 | -2.8% | $3.65 | $3.735 | $3.505 | 5,536,415 |
- Ticker
- BX Swiss:6C1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BX Swiss
- Currency
- CHF
What changed lately
Latest news release · Aug 27, 2026
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
Latest earnings call · Aug 6, 2026
Cytomx Therapeutics (NASDAQ:CTMX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Sep 8, 2026
Wells Fargo 21st Annual Healthcare Conference 2026
Conference · 31 slides
Calls
Replays
Cytomx Therapeutics (NASDAQ:CTMX) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 5:00 PM ET
Watch TranscriptCytomx Therapeutics (NASDAQ:CTMX) Q1 2026 Earnings Call
Thu, May 07, 2026 · 5:00 PM ET
Watch TranscriptCytomx Therapeutics (NASDAQ:CTMX) Q4 2025 Earnings Call
Mon, Mar 16, 2026 · 8:00 AM ET
Watch Transcript
Latest news
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
Aug 27, 2026
Closed $3.42 (+3.0%) on Aug 27, 2026
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update
Aug 6, 2026
Closed $3.46 (+2.7%) on Aug 7, 2026
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
Aug 3, 2026
Closed $3.17 (+2.3%) on Aug 3, 2026
CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
Jul 30, 2026
Closed $3.28 (+3.5%) on Jul 30, 2026
CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors
Jul 27, 2026
Closed $3.25 (+0.3%) on Jul 27, 2026
Decks
Wells Fargo 21st Annual Healthcare Conference 2026
Conference · 31 slides · Sep 8, 2026
Investor Presentation (August 2026)
Investor deck · 32 slides · August 2026
Q4 2025 Earnings Presentation
Earnings · 26 slides · Mar 16, 2026
American Association of Immunologists Annual Meeting 2023 - ICIS Symposium
Conference · 22 slides · May 13, 2023
CytomX Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 172 in all · newest Aug 27, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Aug 6, 2026
- Decks
- 11 decks · latest Sep 8, 2026
Where CytomX Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CTMX · Home listing | NASDAQ | United States | USD |
| gettex:6C1 | gettex | Germany | EUR |
| LS Exchange:A14158 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A14158 | Lang & Schwarz | Germany | EUR |
| Tradegate:6C1 | Tradegate | Germany | EUR |
| Frankfurt:6C1 | Frankfurt | Germany | EUR |
| BOATS:CTMX | BOATS | United States | USD |
| BX Swiss:6C1 · This page | BX Swiss | Switzerland | CHF |
| Dusseldorf:6C1 | Dusseldorf | Germany | EUR |
| Stuttgart:6C1 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about CytomX Therapeutics, Inc.